I have mild COVID – should I take the antiviral Paxlovid?

Mark Morgan, Amanda Gwee, Jason A. Roberts, Nicole Allard, Tari Turner

Research output: Contribution to journalOnline ResourceEducation


The COVID medication Paxlovid has been available in Australia on the Pharmaceuticals Benefits Scheme (PBS) since the start of May, with eligible patients directed to talk to their GP for a prescription.

Paxlovid is an oral treatment for mild COVID, taken as a tablet, which has two active ingredients: nirmatrelvir and ritonavir. Together, they reduce the ability of SARS-CoV-2, the virus that causes COVID, to multiply in your body.
Original languageEnglish
JournalThe Conversation
Publication statusPublished - 27 May 2022


Dive into the research topics of 'I have mild COVID – should I take the antiviral Paxlovid?'. Together they form a unique fingerprint.

Cite this